SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000737207-20-000023
Filing Date
2020-07-06
Accepted
2020-07-06 14:28:05
Documents
50
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atrx-20200331.htm   iXBRL 10-Q 954976
2 EX-31.1 atrx-20200331xex311.htm EX-31.1 12931
3 EX-31.2 atrx-20200331xex312.htm EX-31.2 12961
4 EX-32.1 atrx-20200331xex321.htm EX-32.1 6598
5 EX-32.2 atrx-20200331xex322.htm EX-32.2 6626
  Complete submission text file 0000737207-20-000023.txt   4116633

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20200331.xsd EX-101.SCH 30802
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrx-20200331_cal.xml EX-101.CAL 41731
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrx-20200331_def.xml EX-101.DEF 172868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20200331_lab.xml EX-101.LAB 395697
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20200331_pre.xml EX-101.PRE 260814
11 EXTRACTED XBRL INSTANCE DOCUMENT atrx-20200331_htm.xml XML 584350
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 201013123
SIC: 2834 Pharmaceutical Preparations